Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses-Reference-Cited by-同舟云学术

Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses

Published:2023-06 Issue:6 Volume:56 Page:1341-1358.e11
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Bayerl Felix,Meiser Philippa,Donakonda Sainitin,Hirschberger Anna,Lacher Sebastian B.,Pedde Anna-Marie,Hermann Chris D.,Elewaut Anais,Knolle Moritz,Ramsauer Lukas,Rudolph Thomas J.,Grassmann Simon,Öllinger Rupert,Kirchhammer Nicole,Trefny Marcel,Anton Martina,Wohlleber Dirk,Höchst Bastian,Zaremba Anne,Krüger Achim,Rad Roland,Obenauf Anna C.,Schadendorf Dirk,Zippelius Alfred,Buchholz Veit R.,Schraml Barbara U.,Böttcher Jan P.

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference82 articles.

1. The role of Type 1 conventional dendritic cells in cancer Immunity;Böttcher;Trends Cancer,2018

2. Dendritic cells in cancer immunology and immunotherapy;Wculek;Nat. Rev. Immunol.,2020

3. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control;Böttcher;Cell,2018

4. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity;Broz;Cancer Cell,2014

5. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity;Hildner;Science,2008

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09

2. Ferroptosis in health and disease;Redox Biology;2024-09

3. Innate immune cells in tumor microenvironment: A new frontier in cancer immunotherapy;iScience;2024-09

4. Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade;Veterinary and Comparative Oncology;2024-08-23

5. Tumor-produced immune regulatory factors as a therapeutic target in cancer treatment;Frontiers in Immunology;2024-08-14